Translational virology
Translational virology is the “bench-to-bedside” scientific process of taking basic laboratory research on viruses and applying it to develop real-world medical solutions, such as vaccines, antiviral drugs, and diagnostic tools.
Research expertise
We take basic virology findings around how viruses set up pathogenic infections, and use these findings to develop novel advanced therapies that are better tailored to “on target” therapeutic applications.
These include technologies for applied applications including gene therapy and gene editing technologies to treat genetic diseases, oncolytic immunotherapies to treat cancers, and advanced vaccines to help prevent harm from infectious agents and cancer.
Our expertise therefore combines structural virology, molecular biology, genetics and immunology.
Strategic focus
To turn our basic virological and immunological understanding into products and treatments that can be used to improve the lives of people suffering from viral disease.
Collaboration with team
We build on findings from the basic virology theme to develop novel and more effective medicines, which can move forwards into clinical practise through our epidemiology/clinical practise theme which allows us to deliver those products to patients successfully.
We support viral disease research by producing bespoke viruses, proteins, and organoids, and through mathematical modelling, clinical trials, and public health evaluations.
